Wells Fargo & Company Gritstone Bio, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 29,251 shares of GRTS stock, worth $877. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,251
Previous 29,252 0.0%
Holding current value
$877
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.45 - $0.71 $0 - $0
-1 Reduced -0.0%
29,251 $16,000
Q2 2024

Aug 13, 2024
SELL
$0.62 - $2.35 $7,344 - $27,838
-11,846 Reduced 28.82%
29,252 $18,000
Q1 2024

May 10, 2024
SELL
$1.96 - $2.9 $5,280 - $7,812
-2,694 Reduced 6.15%
41,098 $105,000
Q4 2023

Feb 09, 2024
BUY
$1.28 - $2.85 $22,766 - $50,690
17,786 Added 68.39%
43,792 $89,000
Q3 2023

Nov 13, 2023
SELL
$1.19 - $2.26 $22,599 - $42,919
-18,991 Reduced 42.21%
26,006 $44,000
Q2 2023

Aug 15, 2023
BUY
$1.66 - $3.03 $54,660 - $99,771
32,928 Added 272.83%
44,997 $87,000
Q1 2023

May 12, 2023
BUY
$2.13 - $3.74 $17 - $29
8 Added 0.07%
12,069 $33,000
Q4 2022

Feb 13, 2023
BUY
$2.17 - $3.92 $162 - $294
75 Added 0.63%
12,061 $41,000
Q3 2022

Nov 14, 2022
BUY
$2.46 - $4.75 $100 - $194
41 Added 0.34%
11,986 $31,000
Q2 2022

Aug 12, 2022
SELL
$1.77 - $4.34 $120,885 - $296,408
-68,297 Reduced 85.11%
11,945 $29,000
Q1 2022

May 16, 2022
SELL
$4.03 - $12.19 $203,325 - $615,022
-50,453 Reduced 38.6%
80,242 $331,000
Q4 2021

Feb 14, 2022
SELL
$8.76 - $13.71 $774,042 - $1.21 Million
-88,361 Reduced 40.34%
130,695 $1.68 Million
Q3 2021

Nov 15, 2021
BUY
$6.41 - $13.54 $1.22 Million - $2.57 Million
190,039 Added 654.92%
219,056 $2.37 Million
Q2 2021

Aug 16, 2021
SELL
$8.13 - $10.2 $58,267 - $73,103
-7,167 Reduced 19.81%
29,017 $265,000
Q1 2021

May 13, 2021
BUY
$4.07 - $27.11 $12,787 - $85,179
3,142 Added 9.51%
36,184 $341,000
Q4 2020

Feb 09, 2021
BUY
$2.57 - $4.22 $38,686 - $63,523
15,053 Added 83.68%
33,042 $130,000
Q3 2020

Nov 05, 2020
SELL
$2.63 - $8.09 $15,369 - $47,277
-5,844 Reduced 24.52%
17,989 $48,000
Q2 2020

Aug 13, 2020
SELL
$5.69 - $8.17 $19,198 - $27,565
-3,374 Reduced 12.4%
23,833 $158,000
Q1 2020

May 14, 2020
BUY
$5.47 - $11.3 $148,822 - $307,439
27,207 New
27,207 $158,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email